NCT07135089View on ClinicalTrials.gov

Improving Neuroprotective Strategy for Ischemic Stroke Before Endovascular Thrombectomy by Intravenous Tirofiban

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

884

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

May 31, 2027

Conditions
Stroke, Ischemic
Interventions
DRUG

Intravenous tirofiban before endovascular thrombectomy

The tirofiban was administrated as a bolus dose of 10 μg/kg, followed by continuous infusion of 0.15 μg/kg/min for up to 24 hours.

DRUG

Intravenous placebo before endovascular thrombectomy

The placebo was administrated as a bolus dose of 10 μg/kg, followed by continuous infusion of 0.15 μg/kg/min for up to 24 hours.

Trial Locations (1)

110016

General Hospital of Northern Theater Command, Shenyang

All Listed Sponsors
lead

General Hospital of Shenyang Military Region

OTHER